Human catalase gene promoter haplotype and cardiometabolic improvement after bariatric surgery

Gene. 2018 May 20:656:17-21. doi: 10.1016/j.gene.2018.02.064. Epub 2018 Feb 27.


Although its powerful impact on most co-morbidities has been widely demonstrated, the metabolic outcomes of bariatric surgery (BS) show a great heterogeneity among patients. Haplotypes of one of the major antioxidant enzyme, catalase (CAT), are associated with hypertension, dyslipidemia, and diabetes. The haplotype referred to as CAT1 includes homozygous carriers of CATH1 [-844G,-89A,-20T], whereas CAT2 haplotype includes heterozygous carriers (CATH1/CATH2) and CATH2 homozygous [-844A,-89T,-20C]. The aim of our study was to evaluate the impact of CAT1 and CAT2 haplotypes on traditional cardiovascular and metabolic markers one year after BS in a women population. The 294 women with a body mass index (BMI) >35 kg/m2 were followed-up for one year after BS, monitoring their anthropometric, metabolic and inflammatory parameters. CAT1 patients had significantly improved diastolic blood pressure (DBP) and Creactive protein (CRP) levels compared to CAT2 one year after BS. In untreated women at baseline, the change of CRP one year after BS was higher in CAT1 patients. In the population of women receiving at least one anti-lipidic, anti-hypertensive or anti-diabetic treatment at baseline, DBP and fat mass were lower one year after BS in CAT1 patients and the greater change of fat mass was associated with a higher change of adiponectin. The results highlight the beneficial impact of the CAT1 haplotype on traditional cardiovascular and metabolic parameters after BS. Our findings suggest that the CAT1 haplotype could be implicated in the level of metabolic and cardiovascular improvement after BS.

Keywords: Cardiovascular risk; Catalase; Haplotype; Polymorphisms; Promoter.

MeSH terms

  • Adult
  • Bariatric Surgery* / rehabilitation
  • Blood Glucose / genetics
  • Blood Glucose / metabolism*
  • Cardiovascular System / physiopathology*
  • Catalase / genetics*
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / prevention & control
  • Dyslipidemias / genetics
  • Dyslipidemias / prevention & control
  • Female
  • Genetic Predisposition to Disease
  • Haplotypes
  • Humans
  • Hypertension / genetics
  • Hypertension / prevention & control
  • Male
  • Middle Aged
  • Obesity, Morbid / genetics
  • Obesity, Morbid / metabolism
  • Obesity, Morbid / physiopathology
  • Obesity, Morbid / surgery*
  • Promoter Regions, Genetic*


  • Blood Glucose
  • Catalase